[ET Net News Agency, 15 August 2019] CStone Pharmaceuticals (02616) said its loss
attributable to owners of the company was RMB1.24 billion for the six months ended 30 June
2019, compared to the loss of RMB717.64 million of the same period last year. The loss per
share was RMB1.35. No dividend will be distributed.
The other income was RMB28.62 million, a year-on-year increase of 616.42%. (RC)